Omega Healthcare Investors (NYSE:OHI) Stock Price Expected to Rise, UBS Group Analyst Says

Posted by Francis Steltz on Nov 11th, 2026

Omega Healthcare Investors (NYSE:OHI – Get Free Report) had its target price boosted by research analysts at UBS Group from $52.00 to $56.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the real estate investment trust’s stock. UBS Group‘s price target would indicate a potential upside of 16.35% from the stock’s current price.

A number of other equities analysts have also recently weighed in on the stock. Barclays reduced their price target on shares of Omega Healthcare Investors from $50.00 to $48.00 and set an “underweight” rating on the stock in a research report on Tuesday, October 13th. Citigroup restated a “market outperform” rating on shares of Omega Healthcare Investors in a research report on Wednesday. Raymond James Financial reaffirmed an “outperform” rating and set a $54.00 price objective on shares of Omega Healthcare Investors in a research note on Monday. Wells Fargo & Company reduced their target price on Omega Healthcare Investors from $48.00 to $46.00 and set an “equal weight” rating on the stock in a report on Monday, October 19th. Finally, Cantor Fitzgerald boosted their target price on Omega Healthcare Investors from $52.00 to $56.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $50.27.

Get Our Latest Analysis on Omega Healthcare Investors

Omega Healthcare Investors Trading Down 1.2%

Shares of Omega Healthcare Investors stock traded down $0.57 during trading on Wednesday, reaching $48.13. The company’s stock had a trading volume of 1,520,756 shares, compared to its average volume of 2,076,337. The stock has a 50-day moving average price of $46.41 and a two-hundred day moving average price of $46.73. The stock has a market capitalization of $14.65 billion, a P/E ratio of 19.41, a price-to-earnings-growth ratio of 1.97 and a beta of 0.56. Omega Healthcare Investors has a one year low of $42.18 and a one year high of $52.39.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The real estate investment trust reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.20). The firm had revenue of $340.55 million during the quarter, compared to analyst estimates of $269.16 million. Omega Healthcare Investors had a return on equity of 13.66% and a net margin of 58.11%. Omega Healthcare Investors’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.79 earnings per share. As a group, sell-side analysts anticipate that Omega Healthcare Investors will post 3.12 EPS for the current fiscal year.

Hedge Funds Weigh In On Omega Healthcare Investors

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Advisors Asset Management Inc. bought a new position in shares of Omega Healthcare Investors during the 3rd quarter worth approximately $7,117,000. Private Wealth Asset Management LLC bought a new position in shares of Omega Healthcare Investors during the third quarter worth approximately $295,000. Private Advisor Group LLC increased its holdings in shares of Omega Healthcare Investors by 111.0% during the third quarter. Private Advisor Group LLC now owns 42,624 shares of the real estate investment trust’s stock worth $1,974,000 after purchasing an additional 22,419 shares during the period. Independent Advisor Alliance raised its position in shares of Omega Healthcare Investors by 3.1% in the third quarter. Independent Advisor Alliance now owns 12,412 shares of the real estate investment trust’s stock valued at $579,000 after buying an additional 377 shares in the last quarter. Finally, Composition Wealth LLC raised its position in shares of Omega Healthcare Investors by 31.0% in the third quarter. Composition Wealth LLC now owns 9,375 shares of the real estate investment trust’s stock valued at $434,000 after buying an additional 2,216 shares in the last quarter. 65.25% of the stock is owned by institutional investors.

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT) focused on healthcare facilities, particularly skilled nursing and assisted living properties. The company invests in these facilities through real estate leases, loans and other financing arrangements. Its portfolio serves healthcare operators in the United States and the United Kingdom. Omega primarily leases properties to third-party operators, which manage the facilities and provide care to residents. Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega is led by President and Chief Executive Officer Taylor Pickett.